Apertura Gene Therapy Showcases Advancements in Capsid Engineering Platform in Presentations at ASGCT Annual Meeting
GlobeNewswire
– Significant advancements in engineering neutralizing antibody (NAb) evasion properties into receptor-targeted capsids,..